Zealand Pharma applies for FDA approval for blood sugar treatment
Zealand Pharma has sent dasiglucagon, which is a treatment for low blood sugar administered through auto-injector Hypopal, for approval at the FDA.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.